| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/06/2000 | CA2352896A1 Pyrimidine compounds |
| 07/06/2000 | CA2351724A1 1h-imidazo¬4,5-d|pyridazin-7-ones, 3h-imidazo¬4,5-c|pyridin-4-ones and corresponding thiones as corticotropin releasing factor (crf) receptor ligands |
| 07/06/2000 | CA2351539A1 Method for preparing (r)- (+) -3 {1- ¬2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl|- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | CA2347671A1 Succinoylamino benzodiazepines as inhibitors of a.beta. protein production |
| 07/05/2000 | EP1016664A1 Fused thiophene compounds and medicinal use thereof |
| 07/05/2000 | EP1015572A2 Nuclear transfer with differentiated fetal and adult donor cells |
| 07/05/2000 | EP1015566A1 Human ste20-like stress activated serine/threonine kinase |
| 07/05/2000 | EP1015473A1 CLONING AND EXPRESSION OF betaAPP-C100 RECEPTOR (C100-R) |
| 07/05/2000 | EP1015457A1 1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives as ampa/kainate receptor inhibitors |
| 07/05/2000 | EP1015451A1 Tetrahydro gamma-carbolines |
| 07/05/2000 | EP1015447A1 Piperidinylmethyloxazolidinone derivative |
| 07/05/2000 | EP1015446A1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/05/2000 | EP1015433A1 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine-10-oles, method for the production and use thereof as medicaments |
| 07/05/2000 | EP1015431A1 2-aminopyridines as inhibitors of cyclooxygenase-2 |
| 07/05/2000 | EP1015421A1 New phenylamidine derivatives, a process for preparing the same and their use as medicaments |
| 07/05/2000 | EP1015416A2 Method for the preparation of citalopram |
| 07/05/2000 | EP1015038A1 Methods for the detection, treatment, and prevention of neurodegeneration |
| 07/05/2000 | EP1015029A1 Compound inhibiting presenilin 1 for preparing a medicine and a diagnostic agent |
| 07/05/2000 | EP1015019A1 Compositions and methods of therapy for igf-i-responsive conditions |
| 07/05/2000 | EP1014996A1 Specific saccharide compositions and methods for treating alzheimer's disease and other amyloidoses |
| 07/05/2000 | EP1014994A1 Phosphono-carboxylate compounds for treating amyloidosis |
| 07/05/2000 | EP1014986A1 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT 1 BETA ANTAGONIST OR PARTIAL AGONIST |
| 07/05/2000 | EP1014985A1 A COMBINATION OF A 5-HT REUPTAKE INHIBITOR AND A h5-HT 1B ANTAGONIST OR PARTIAL AGONIST |
| 07/05/2000 | EP1014981A1 Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime |
| 07/05/2000 | EP1014978A1 Method of using neutrophic sulfonamide compounds |
| 07/05/2000 | EP1014977A1 Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes |
| 07/05/2000 | EP1014976A1 Novel substituted imidazole compounds |
| 07/05/2000 | EP1014975A1 Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
| 07/05/2000 | EP1014974A1 Treatment of schizophrenia and psychosis |
| 07/05/2000 | EP1014966A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 07/05/2000 | EP1014961A1 Improved treatment of migraine headache |
| 07/05/2000 | EP1014960A1 Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing |
| 07/05/2000 | EP1014886A1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor |
| 07/05/2000 | EP0821676B1 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants |
| 07/05/2000 | EP0734381B1 Morpholine tachykinin receptor antagonists |
| 07/05/2000 | EP0711296B1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZOL[5,1-c][1,4]BENZOXAZIN-1-ONE AND THEIR USE AS THERAPEUTIC AGENTS |
| 07/05/2000 | EP0711293B1 IMIDAZOLYLALKYL DERIVATIVES OF IMIDAZO[1,5-a]INDOL-3-ONE AND THEIR USE AS THERAPEUTIC AGENTS |
| 07/05/2000 | EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists |
| 07/05/2000 | EP0626961B1 Process for the preparation of cyano-methoxyiminomethyl derivatives |
| 07/05/2000 | EP0554436B1 Gaba receptor modulators |
| 07/05/2000 | EP0528891B1 Method for increasing blood-brain barrier permeability |
| 07/05/2000 | CN1259140A Treatment of insulin resistance with growth hormone secretagogues |
| 07/05/2000 | CN1259132A Compounds |
| 07/05/2000 | CN1259131A Compounds |
| 07/05/2000 | CN1259127A Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic |
| 07/05/2000 | CN1259126A Pharmacological agents |
| 07/05/2000 | CN1259049A Carboxamides useful as 5-HT1F agonists |
| 07/05/2000 | CN1258748A Preparation and application of rhBTR gene and gene probe |
| 07/05/2000 | CN1054123C Process for producing carbamic acid derivatives |
| 07/05/2000 | CN1054060C Ginseng candy for giving up smoking |
| 07/05/2000 | CA2293928A1 A novel substituted alkyltetraamine derivative |
| 07/04/2000 | US6084130 For treatment of central nervous system disorders |
| 07/04/2000 | US6084103 Forming a carbamate from methyl 4-nitro-(l)-phenylalaninate hydrochloride; reducing the nitro and ester groups; ring closure free of phosgene; forming a diazonium salt without using tin chloride; fischer reaction; migraines; 5ht1-agonist |
| 07/04/2000 | US6084084 Nucleotide and amino acid sequences; for anticonvulsants, neuroprotectants, analgesics and cognition enhancers; for diagnosis and therapy of related nervous system disorders |
| 07/04/2000 | US6084075 Agonist and antagonist antibodies to the chemokine receptor-2 (CCR2) |
| 07/04/2000 | US6083987 Phenylenediamine derivative, radical scavenger, brain-infarction depressant, and brain-edema depressant |
| 07/04/2000 | US6083981 Sulfonamide substituted aspartic acid interleukin-1β converting enzyme inhibitors |
| 07/04/2000 | US6083960 Constrained somatostatin agonists and antagonists |
| 07/04/2000 | US6083957 Heterocyclic compounds and their preparation and use |
| 07/04/2000 | US6083952 Compounds |
| 07/04/2000 | US6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists |
| 07/04/2000 | US6083948 Treating anxiety, depression, and other psychiatric and neurological disorders |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 07/04/2000 | US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/04/2000 | US6083926 Water soluble vitamin B12 receptor modulating agents and methods related thereto |
| 07/04/2000 | US6083920 Treating nervous system disorders by administering lysocerebroside or lysosphingomyelin |
| 07/04/2000 | US6083904 Therapeutic and diagnostic methods and compositions based on notch proteins and nucleic acids |
| 07/04/2000 | US6083713 Nucleotide sequences coding binding polypeptide for the terminal domain of the amyloid precursor protein; for the diagnosis and design of drugs for treatment of alzheimer's disease |
| 07/04/2000 | US6083536 Super-critical lipid extract from mussels having anti-inflammatory activity |
| 07/04/2000 | US6083521 Drugs and polyethylene carbonates |
| 07/04/2000 | CA2025212C (2-imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 06/29/2000 | WO2000037944A1 Kidney disease detection and treatment |
| 06/29/2000 | WO2000037685A2 Method of identifying a psychotropic agent using differential gene expression |
| 06/29/2000 | WO2000037642A1 Method of enhancing the biological activity of ligands |
| 06/29/2000 | WO2000037639A2 Lymphocytic membrane proteins |
| 06/29/2000 | WO2000037616A1 Compounds, methods of screening and methods of treatment for central and peripheral nervous system disorders |
| 06/29/2000 | WO2000037500A1 Three dimensional structure of a sterile alpha motif domain |
| 06/29/2000 | WO2000037483A1 Protein-protein interactions in neurodegenerative disorders |
| 06/29/2000 | WO2000037481A1 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb¿1? |
| 06/29/2000 | WO2000037474A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| 06/29/2000 | WO2000037471A1 2-amino-9-alkylpurines: gaba brain receptor ligands |
| 06/29/2000 | WO2000037466A1 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS |
| 06/29/2000 | WO2000037462A1 Non-peptide nk1 receptors antagonists |
| 06/29/2000 | WO2000037456A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
| 06/29/2000 | WO2000037452A1 Sulphonyloxazolamines as therapeutic active ingredients |
| 06/29/2000 | WO2000037441A1 Melatonin derivatives and medicine containing same |
| 06/29/2000 | WO2000037438A1 Novel thio-aminotetralin compounds useful in pain management |
| 06/29/2000 | WO2000037426A1 Novel oxo-aminotetralin compounds useful in pain management |
| 06/29/2000 | WO2000037423A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 06/29/2000 | WO2000037422A2 Ion channel modulating agents |
| 06/29/2000 | WO2000037111A1 Mammalian cell preparations optionally transfected with a gene coding for an active substance containing same |
| 06/29/2000 | WO2000037103A2 Compounds for intracellular delivery of therapeutic moieties to nerve cells |
| 06/29/2000 | WO2000037092A1 Method of using steam ironing of fabrics as a way of causing reduction of physiological and/or subjective reactivity to stress in humans |
| 06/29/2000 | WO2000037089A1 Cyclic adenosine diphosphate ribose analogues for modulating t cell activity |
| 06/29/2000 | WO2000037088A1 Use of etherlysophospholipids as antiinflammatory agents |
| 06/29/2000 | WO2000037084A1 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |
| 06/29/2000 | WO2000037073A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome |
| 06/29/2000 | WO2000037064A2 Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma |